Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Curr Oncol. 2023 Feb 25;30(3):2761-2769. doi: 10.3390/curroncol30030209.
Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical.
腹膜后肉瘤切除后的复发较为常见,且因组织学亚型而异。复发模式也受组织学影响(例如,分化良好的脂肪肉瘤更可能局部复发,而平滑肌肉瘤更可能发生远处转移)。在有限的情况下,放射治疗可能提供有效的局部区域控制,且化疗的数据也很少。对于局部复发性疾病的手术与最大的生存获益相关;然而,数据是回顾性的,且来自高度选择的患者亚组。有限的回顾性数据也表明,切除有限的远处转移与生存相关。鉴于这些患者的复杂性,在高容量肉瘤中心进行多学科评估至关重要。